# Progyny, Inc.

> Progyny is a New York-based benefits company that sells fertility and family-building coverage to large employers, then wraps it in a concierge model built around dedicated care advocates, a curated network of top clinics, and a bundled treatment currency called the Smart Cycle. What began as a fertility information website became a public company on Nasdaq in 2019, and now serves roughly 530-plus employers and millions of covered employees while reporting better clinical outcomes than the national IVF average.

- **Founded:** 2008
- **Headquarters:** New York, United States
- **Founders:** Gina Bartasi (Founder (FertilityAuthority, 2008)), David Schlanger (CEO 2016-2023, Board Director)
- **Team size:** ~860 employees
- **Products:** Smart Cycle, Progyny Rx, Patient / Progyny Care Advocates (PCAs), Pregnancy & Postpartum Care, Menopause & Midlife Care
- **Notable:** IPO on Nasdaq (PGNY) in October 2019, with shares rising about 23% on the first day of trading, Grew from 5 employer clients in 2016 to 530+ by 2025, FY2024 revenue of $1.167B with $198.8M adjusted EBITDA

## Products & services

- **Smart Cycle** — Progyny's proprietary treatment currency - roughly 19 bundled, customizable units covering diagnostics, genetic testing and procedures with no dollar maximums, so members receive complete treatment courses rather than capped benefits.
- **Progyny Rx** — Integrated fertility pharmacy that manages medication for members, reducing drug cost and waste with fast delivery. It accounts for roughly a third of company revenue.
- **Patient / Progyny Care Advocates (PCAs)** — Dedicated concierge support staff with clinical, nursing and social-work backgrounds who guide each member through treatment, averaging about 15 touchpoints per cycle.
- **Pregnancy & Postpartum Care** — Maternity program with clinical coaching, lactation support and doula services (added March 2025 via a Pacify partnership).
- **Menopause & Midlife Care** — Support programs extending Progyny's women's-health coverage into menopause and midlife, adopted by clients representing over 1.5M lives.
- **Adoption & Surrogacy Benefits** — Reimbursement programs supporting members building families through adoption and surrogacy.
- **Progyny Select** — A fully insured supplemental fertility and women's-health plan, described by the company as an industry first.

## Achievements

- IPO on Nasdaq (PGNY) in October 2019, with shares rising about 23% on the first day of trading
- Grew from 5 employer clients in 2016 to 530+ by 2025
- FY2024 revenue of $1.167B with $198.8M adjusted EBITDA
- Reports IVF live-birth rates roughly 23% above the national average and far fewer multiples
- CEO Pete Anevski named to the TIME100 Health list (2025)
- Named to CNBC's Disruptor 50 (2018 and 2019) and TIME Most Influential Companies

## Latest updates

- **2025-06** — Progyny became the first women's health and family-building solution in Amazon's Health Benefits Connector program.
- **2025-04** — Named Melissa Cummings its first Chief Operating Officer and Geoffrey Clapp its first Chief Product Officer.
- **2025-03** — Added doula services to its maternal-health program through a partnership with Pacify.
- **2025-02** — Reported FY2024 revenue of $1.167B and issued 2025 guidance of $1.175B-$1.225B.

## Links

- Website: https://progyny.com
- LinkedIn: https://www.linkedin.com/company/progyny/
- Twitter/X: https://twitter.com/Progyny
- YouTube: https://www.youtube.com/channel/UCxjpBP09OnyISjeHE4M7pTA
- Instagram: https://www.instagram.com/progynyinc/
- Facebook: https://www.facebook.com/Progyny/

---

Profile page: https://yespress.io/progyny-inc
Published by YesPress — https://yespress.io
Last updated: 2026-08-13